Factors associated with survival following allogeneic transplantation for myeloid neoplasms harboring TP53 mutations.

Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T cell lymphoma.

First-in-human trial of engineered NK cells in lung cancer refractory to immune checkpoint inhibitors.

Collaborative large language models for automated data extraction in living systematic reviews.

Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma.

Combined photodynamic therapy and transpupillary thermotherapy for small choroidal melanoma.

FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): the Mayo Clinic experience.

Iris melanoma in an Australian cohort.

Collaborative Large Language Models for Automated Data Extraction in Living Systematic Reviews.

Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis.